On Sunday April 7th we will welcome our colleagues and collaborators from the PlaqOmics consortium for a two-days progress meeting.
PlaqOmics is funded by the Leducq Foundation for a total of 5 years. We started in Autumn 2018 and we have next week our first progress meeting.
40 scientists, from senior to junior researcher, will discuss our hypothesis that detrimental reprogramming of smooth muscle cells (SMC) destabilizes atherosclerotic plaques and that there are critical genetic determinants of coronary artery disease risk that act in part by impacting SMC phenotypic transitions.
More information about PlaqOmics can be found here: www.plaqomics.com